What’s Going On with PSTX Stock? News of the acquisition has sent PSTX stock surging this morning. Shares have skyrocketed 225% since markets opened, and they are showing no signs of slowing down.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...
Poseida Therapeutics (NASDAQ:PSTX) just reported results for the second quarter of 2024. Poseida Therapeutics reported earnings per share of -32 cents. This was above the analyst estimate for EPS of ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Poseida Therapeutics, Inc. (NASDAQ: PSTX) to Roche Holdings, Inc. for $9.00 per share in ...
Update 9:40 PM EST: Adds comments from Poseida. Shares of Poseida Therapeutics (NASDAQ:PSTX) traded higher on Wednesday after the U.S. Food and Drug Administration (FDA) granted its orphan drug ...
Poseida Therapeutics, Inc. (PSTX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
Poseida Therapeutics (NASDAQ:PSTX) just reported results for the first quarter of 2024. Poseida Therapeutics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results